Peer Review History

Original SubmissionDecember 12, 2020
Decision Letter - Robert Jeenchen Chen, Editor

PONE-D-20-38300

Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery

PLOS ONE

Dear Dr. Plicner,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please address the reviewers' issues and revise accordingly. 

Please submit your revised manuscript by Feb 26 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Robert Jeenchen Chen, MD, MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records/samples used in your retrospective study, includinga) the date range (month and year) during which patients' medical records/samples were accessed; b) the source of the medical records/samples analyzed in this work (e.g. hospital, institution or medical center name).

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I would like to commend the authors on this study. CDiff infections continue to be a morbidity in surgical fields and it is important for us to better understand it in cardiac surgery. There are a couple of issues I would like to communicate with this manuscript.

1. Please indicate what type of operations the patients undergo and the clamp and bypass times for these operations. It would be important to know if increased bypass and clamp times have an effect on cdiff operations.

2. Having different types of preoperative antibiotics may have an effect on cdiff infections. What is the reasoning for using these different types of antibiotics instead of having the standard. How about post-op antibiotics. At our institution, we usually continue antibiotics for another 3-5 doses post-operatively.

3. It is possible to take a look at patients who did not have postoperative infections requiring antibiotics. This way, we can isolate those patients who did not require escalation in antibiotics who developed cdiff. We already know additional or escalating antibiotics is a risk factor for cdiff infections. In the same manner, should we considering doing the same with endocarditis patients.

Thank you for the manuscript.

Reviewer #2: Dear the authors of the manuscript entitled "Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery"

Thank you for writing this manuscript which highlights an important issue in the field of cardiac surgery. it is unique experiment and well formed. the manuscript is well written and the results and conclusion are beneficial to the readers

I have no concerns

thank you

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: salah eldien Altarabsheh

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Reviewer of PLOS ONE,

Thank you very much for your patience and all the valuable comments and suggestions. I tried my best to address all your concerns. Please find my answers below.

Sincerely yours,

Dariusz Plicner on behalf of the authors.

1. Please indicate what type of operations the patients undergo and the clamp and bypass times for these operations. It would be important to know if increased bypass and clamp times have an effect on cdiff operations.

Ad. 1 We performed additional calculations according to your recommendations.

The most common surgical procedures performed in the analyzed groups of patients were heart valve surgery and CABG (for CDI patients: 37.8% and 37.1% and for non-CDI patients: 28.0% and 46.5%, respectively). There was no difference between groups in the type of operations (p = 0.448).

Patients with CDI had longer cardiopulmonary bypass time than the control group (p = 0.01), but there were no correlations between CDI occurrence and aortic cross-clamp time (p = 0.144 ).

We added the above findings to the results section (p. 10, lines 176-178, 181-182 and Table 3) and discussion (p. 14, lines 258-260).

2. Having different types of preoperative antibiotics may have an effect on cdiff infections. What is the reasoning for using these different types of antibiotics instead of having the standard. How about post-op antibiotics. At our institution, we usually continue antibiotics for another 3-5 doses post-operatively.

Ad. 2 At our institution, each patient who undergoes cardiac surgery receives periprocedural antimicrobial prophylaxis, based on the first generation of cephalosporins (cefazolin). This is also continued for another 3-5 doses postoperatively. Only in cases of history of allergy to cephalosporins or penicillin, clindamycin was administered. There was no difference in the type of perioperative antimicrobial prophylaxis used in the patients with and without CDI (92% vs 94 %, respectively, p = 0.537).

In compliance with your suggestions we added this information to the methods section (p. 5, lines 92-94) and results (p. 10, lines 179-180).

3. It is possible to take a look at patients who did not have postoperative infections requiring antibiotics. This way, we can isolate those patients who did not require escalation in antibiotics who developed cdiff. We already know additional or escalating antibiotics is a risk factor for cdiff infections. In the same manner, should we considering doing the same with endocarditis patients.

Ad. 3 Thank you for this valuable comment. It offers a very interesting and broad subject for our next study. We already have a large group of patients collected from 2014. We also believe that this is an important area to study which is why we mentioned this problem in the limitations section (p. 16, lines 292-298).

Attachments
Attachment
Submitted filename: Answers to Reviewers.docx
Decision Letter - Robert Jeenchen Chen, Editor

Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery

PONE-D-20-38300R1

Dear Dr. Plicner,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Robert Jeenchen Chen, MD, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for revising your manuscript and addressing all of my points in a point by point fashion. Obviously, there are limitations to your work and you have addressed them in the limitations section. I believe your further studies will be very interesting. THank you for submitting your work.

Reviewer #2: Thank you very much for taking care of the reviewers comments. I have no concerns about this manuscript

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: salah eldien Altarabsheh

Formally Accepted
Acceptance Letter - Robert Jeenchen Chen, Editor

PONE-D-20-38300R1

Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery

Dear Dr. Plicner:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Robert Jeenchen Chen

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .